ProCE Banner Activity

Advances in Gynecologic Cancers: Expert Insight for Incorporating New Clinical Evidence

Slideset Download
Download this slideset associated with the online text module on gynecologic cancer advances, in which experts Ritu Salani, MD, MBA, and Eva Y. Pan, PharmD, BCOP, discuss the best strategies for optimizing management approaches for patients with ovarian, endometrial, and cervical cancers.

Released: May 13, 2022

Expiration: May 12, 2023

No longer available for credit.

Share

Faculty

Eva Y. Pan

Eva Y. Pan, PharmD, BCOP

Clinical Oncology Pharmacy Specialist
Yale-New Haven Hospital
New Haven, Connecticut

Ritu Salani

Ritu Salani, MD, MBA

Professor and Division Director
OB/GYN and Gynecologic Oncology
University of California, Los Angeles
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme

Faculty Disclosure

Primary Author

Eva Y. Pan, PharmD, BCOP

Clinical Oncology Pharmacy Specialist
Yale-New Haven Hospital
New Haven, Connecticut

Eva Y. Pan, PharmD, BCOP, has no relevant conflicts of interest to report.

Ritu Salani, MD, MBA

Professor and Division Director
OB/GYN and Gynecologic Oncology
University of California, Los Angeles
Los Angeles, California

Ritu Salani, MD, MBA, has disclosed that she has received consulting fees from Arcus Biosciences, Genentech, GlaxoSmithKline, Instil Bio, Merck, and Seagen, and research support from Regeneron Pharmaceuticals.